|
× |
 |
Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Droperidol: Efficacy and Side Effects in Psychiatric Emergencies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System PDF |
$40.00 |
|
$40.00 |
|
× |
|
Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome PDF |
$40.00 |
|
$40.00 |
|
× |
|
Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review PDF |
$40.00 |
|
$40.00 |
|
× |
|
Catatonia and Psychosis Associated With Hyperthyroidism PDF |
$40.00 |
|
$40.00 |
|
|
